Immunomodulating drugs

ANTI-?-ARRESTIN1 ANTIBODY CLONE F7C2 RABBIT MONOCLONAL

ANTI-?-CATENIN/P120 CATENIN ANTIBODY CLONE 5N7Z0 RABBIT MONOCLONAL

ANTI-?-SMOOTH MUSCLE ACTIN (ACTA2) ANTIBODY CLONE 2V4L9 RABBIT MONOCLONAL

ANTI-?-SYNUCLEIN ANTIBODY CLONE 10Y4X3 RABBIT MONOCLONAL

ANTI-?III-TUBULIN ANTIBODY CLONE 6X6H6 RABBIT MONOCLONAL

ANTI-[KD VALIDATED] TRAF2 ANTIBODY CLONE 3S2A8 RABBIT MONOCLONAL

General description ZooMAb &#174: antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb &#174: antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and

General description ZooMAb &#174: antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb &#174: antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and

Purified mouse monoclonal antibody generated by immunizing Balb/c57 mice with the specified immunogen and fusing splenocytes with NS-1 mouse myeloma cells. Recognizes the ~60 kDa tubulin protein.

Immunogen alpha-1-B glycoprotein Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the

General description Mammalian apolipoprotein B mRNA undergoes site-specific C to U deamination, which is mediated by a multi-component enzyme complex containing a minimal core composed of APOBEC-1 and a complementation factor encoded by this gene.

Immunogen APOBEC1 complementation factor recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are